Covid-19
Showing NaN - NaN of 67
COVID-19, SARS-CoV-2 Infection Trial in United States (AZD9838, Licensed mRNA vaccine)
Not yet recruiting
- COVID-19
- SARS-CoV-2 Infection
- AZD9838
- Licensed mRNA vaccine
-
Long Beach, California
- +4 more
Nov 24, 2023
COVID-19 Trial in Chicago (Experimental: Primary Cohort, Placebo Comparator: Primary Cohort - Placebo)
Active, not recruiting
- COVID-19
- Experimental: Primary Cohort
- Placebo Comparator: Primary Cohort - Placebo
-
Chicago, IllinoisUniversity of Chicago
Aug 24, 2023
Rheumatic Diseases, COVID-19 Vaccine, COVID-19 Trial in Chicago (COVID-19 vaccine and booster training, and importance)
Not yet recruiting
- Rheumatic Diseases
- +3 more
- COVID-19 vaccine and booster training, and importance
-
Chicago, IllinoisNorthwestern University
Apr 7, 2023
COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)
Recruiting
- COVID-19
- mRNA-1283.222
- mRNA-1273.222
-
Birmingham, Alabama
- +209 more
Apr 13, 2023
COVID-19 Trial in Worldwide (AZD7442, Placebo)
COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)
Completed
- COVID-19
- +2 more
- pathogen reduced SARS-CoV-2 convalescent plasma
- Placebo
-
Little Rock, Arkansas
- +25 more
Oct 6, 2022
Long Term Outcomes of Patients With COVID-19
Active, not recruiting
- Critical Illness
- +3 more
- Quality of Life
- +2 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Nov 1, 2022
Infection Viral, Thromboses, Venous, COVID-19 Trial in United States (Enoxaparin Prefilled Syringe [Lovenox])
Completed
- Infection Viral
- +2 more
- Enoxaparin Prefilled Syringe [Lovenox]
-
Birmingham, Alabama
- +15 more
Sep 15, 2022
COVID-19, Burnout, Burnout, Professional Trial in Chicago (Positive Affect Regulation sKills (PARK))
Recruiting
- COVID-19
- +5 more
- Positive Affect Regulation sKills (PARK)
-
Chicago, IllinoisNorthwestern University
Sep 28, 2022
SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19
Completed
- SARS-CoV Infection
- +3 more
- Moderna COVID-19 Vaccine
- +2 more
-
Tucson, Arizona
- +28 more
Sep 19, 2022
COVID-19, SARS-CoV-2 Trial in United States (Ascorbic Acid, Hydroxychloroquine Sulfate, Azithromycin)
Terminated
- COVID-19
- SARS-CoV-2
- Ascorbic Acid
- +4 more
-
Chicago, Illinois
- +5 more
Jul 12, 2022
COVID-19 Trial in Worldwide (SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent), SARS-CoV-2 adjuvanted recombinant
Active, not recruiting
- COVID-19
- SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent)
- +2 more
-
Birmingham, Alabama
- +93 more
Jul 22, 2022
COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)
Completed
- COVID-19
- Lenzilumab
- +2 more
-
Birmingham, Alabama
- +55 more
Jul 21, 2022